News 12 February 2026 - 13 February 2026

MercadoLibre stock tumbles as MELI hits 52-week low after Q4 results

MercadoLibre stock tumbles as MELI hits 52-week low after Q4 results

MercadoLibre shares fell about 9% to $1,748.10 Wednesday, hitting a new 52-week low after fourth-quarter profit missed estimates. Net income reached $559 million, below analysts’ $587 million forecast, as heavy spending and a 90% jump in the credit portfolio squeezed margins. Operating margin dropped to 10.1% from 13.5% a year earlier. Cantor Fitzgerald and others cut their price targets after the results.
February 25, 2026
DraftKings stock sinks after weak 2026 forecast as prediction-markets spend takes focus

DraftKings stock sinks after weak 2026 forecast as prediction-markets spend takes focus

DraftKings shares dropped 13% in after-hours trading Thursday after its 2026 revenue and profit outlook missed Wall Street estimates. The company reported fourth-quarter revenue up 43% to $1.99 billion and posted positive net income for 2025. Monthly unique payers were flat at 4.8 million. DraftKings cited increased investment in its Predictions product ahead of 2026 launches.
February 12, 2026
US mortgage rate dips to 6.09% — a small break for buyers as spring nears

US mortgage rate dips to 6.09% — a small break for buyers as spring nears

U.S. 30-year fixed mortgage rates fell to 6.09% from 6.11% last week, Freddie Mac said Thursday. Existing home sales dropped 8.4% in January, with inventory at 1.22 million homes, according to the National Association of Realtors. Payrolls rose by 130,000 last month and unemployment held at 4.3%. The Labor Department will release January inflation data Friday morning.
February 12, 2026
Coinbase posts $667 million loss as crypto rout drags revenue down — and the Q1 clue traders seized on

Coinbase posts $667 million loss as crypto rout drags revenue down — and the Q1 clue traders seized on

Coinbase posted a $667 million fourth-quarter loss as net revenue fell 22% to $1.71 billion, missing analyst estimates. Transaction revenue dropped to $983 million, driven by a sharp fall in consumer activity after a late-2025 crypto selloff. Subscription and services revenue climbed 13% to $727 million, boosted by stablecoins. Shares fell about 8% after the report.
February 12, 2026
Rivian stock lifts on R2 launch timeline, but 2026 outlook points to more losses

Rivian stock lifts on R2 launch timeline, but 2026 outlook points to more losses

Rivian forecast 2026 deliveries of 62,000 to 67,000 vehicles, up from 42,247 in 2025, as it prepares to launch the R2 SUV in the second quarter. The company posted $1.29 billion in fourth-quarter revenue and $120 million in gross profit, but reported a net loss of $804 million. Rivian guided to an adjusted EBITDA loss of $1.8 billion to $2.1 billion and capital spending up to $2.05 billion this year.
February 12, 2026
Pinterest earnings: Stock drops on weak Q1 revenue outlook as AI pivot faces a tougher ad fight

Pinterest earnings: Stock drops on weak Q1 revenue outlook as AI pivot faces a tougher ad fight

Pinterest forecast first-quarter revenue of $951 million to $971 million, missing analysts’ $980.1 million estimate. Shares dropped about 12% in after-hours trading following the outlook. Fourth-quarter revenue rose 14% to $1.319 billion, with monthly active users reaching 619 million. The company recently announced job cuts affecting less than 15% of its workforce.
February 12, 2026
Merck (MRK) stock swings, ends flat after FDA clears Keytruda regimen in ovarian cancer

Merck (MRK) stock swings, ends flat after FDA clears Keytruda regimen in ovarian cancer

Merck shares closed down 0.03% at $119.28 after the FDA approved a Keytruda-based regimen for certain platinum-resistant ovarian cancer patients. The stock had reached $121.62 earlier in the session. Merck also announced new bladder and kidney cancer data to be presented at ASCO GU later this month. Chief Marketing Officer Chirfi Guindo sold 10,000 shares at an average price of $121.46.
February 12, 2026
Waters Corporation stock drops again as analysts reset targets after BD deal

Waters Corporation stock drops again as analysts reset targets after BD deal

Waters Corp shares fell 2.8% to $320 in late New York trading Thursday, extending losses after a weak first-quarter profit outlook and broker price target cuts. Wells Fargo, BofA, UBS, and TD Cowen all lowered targets, citing integration risks with BD’s biosciences and diagnostics units. Waters completed the $18.8 billion BD deal this week, with BD shareholders now owning 39.2% of the combined company.
February 12, 2026
AST SpaceMobile stock slides 16% after $1 billion convertible notes, share sale plan grabs the tape

AST SpaceMobile stock slides 16% after $1 billion convertible notes, share sale plan grabs the tape

AST SpaceMobile shares fell 16% to $81.14 in after-hours trading Thursday after the company announced a $1 billion convertible note offering tied to its satellite buildout. Trading volume topped 27 million shares. AST reported $2.78 billion in year-end cash and preliminary 2025 revenue of $63–71 million. The new notes are set to settle Feb. 17, with related transactions expected around Feb. 20.
February 12, 2026
Wells Fargo stock drops again as WFC slides with banks ahead of Friday CPI

Wells Fargo stock drops again as WFC slides with banks ahead of Friday CPI

Wells Fargo shares fell 2.7% to $86.53 Thursday afternoon, underperforming U.S. financial stocks ahead of Friday’s inflation data. The Financial Select Sector SPDR Fund dropped 1.5%, while the S&P 500 ETF slipped 1.2%. Investors adjusted bets on Federal Reserve rate cuts after a strong jobs report. Wells Fargo management cited loan growth in cards and autos, with credit performance holding steady.
February 12, 2026
Accenture stock price slides nearly 4% as CEO share sale, AI jitters weigh on ACN

Accenture stock price slides nearly 4% as CEO share sale, AI jitters weigh on ACN

Accenture shares fell 3.8% to $221.58 Thursday after touching $215.22 intraday, with about 7.5 million shares traded. CEO Julie Sweet disclosed a planned sale of 6,057 shares in an SEC filing. Traders are watching the March 19 earnings call and a May 20 GAO deadline on a $1.4 billion federal contract protest. Peers IBM, Cognizant, DXC, and Infosys also declined.
February 12, 2026
Boston Scientific stock edges higher as Wall Street slides — what’s next for BSX shares

Boston Scientific stock edges higher as Wall Street slides — what’s next for BSX shares

Boston Scientific shares rose 1.2% to $74.38 Thursday, outperforming a 1% drop in U.S. indexes as tech stocks sold off ahead of Friday’s CPI report. The stock remains volatile after a 17% plunge last week, triggered by weaker-than-expected electrophysiology sales and a slower 2026 growth forecast. CEO Michael Mahoney recently sold shares under a pre-set plan. Stryker and Medtronic shares also gained in Thursday trading.
February 12, 2026
1 76 77 78 79 80 155